Skip to main content
Top
Published in: Arthritis Research & Therapy 2/2007

Open Access 01-04-2007 | Research article

High abundance synovial fluid proteome: distinct profiles in health and osteoarthritis

Authors: Reuben Gobezie, Alvin Kho, Bryan Krastins, David A Sarracino, Thomas S Thornhill, Michael Chase, Peter J Millett, David M Lee

Published in: Arthritis Research & Therapy | Issue 2/2007

Login to get access

Abstract

The development of increasingly high-throughput and sensitive mass spectroscopy-based proteomic techniques provides new opportunities to examine the physiology and pathophysiology of many biologic fluids and tissues. The purpose of this study was to determine protein expression profiles of high-abundance synovial fluid (SF) proteins in health and in the prevalent joint disease osteoarthritis (OA). A cross-sectional study of 62 patients with early OA (n = 21), patients with late OA (n = 21), and control individuals (n = 20) was conducted. SF proteins were separated by using one-dimensional PAGE, and the in-gel digested proteins were analyzed by electrospray ionization tandem mass spectrometry. A total of 362 spots were examined and 135 high-abundance SF proteins were identified as being expressed across all three study cohorts. A total of 135 SF proteins were identified. Eighteen proteins were found to be significantly differentially expressed between control individuals and OA patients. Two subsets of OA that are not dependent on disease duration were identified using unsupervised analysis of the data. Several novel SF proteins were also identified. Our analyses demonstrate no disease duration-dependent differences in abundant protein composition of SF in OA, and we clearly identified two previously unappreciated yet distinct subsets of protein profiles in this disease cohort. Additionally, our findings reveal novel abundant protein species in healthy SF whose functional contribution to SF physiology was not previously recognized. Finally, our studies identify candidate biomarkers for OA with potential for use as highly sensitive and specific tests for diagnostic purposes or for evaluating therapeutic response.
Appendix
Available only for authorised users
Literature
1.
go back to reference Brooks PM: Impact of osteoarthritis on individuals and society: how much disability? Social consequences and health economic implications. Curr Opin Rheumatol. 2002, 14: 573-577. 10.1097/00002281-200209000-00017.CrossRefPubMed Brooks PM: Impact of osteoarthritis on individuals and society: how much disability? Social consequences and health economic implications. Curr Opin Rheumatol. 2002, 14: 573-577. 10.1097/00002281-200209000-00017.CrossRefPubMed
2.
go back to reference Elders MJ: The increasing impact of arthritis on public health. J Rheumatol Suppl. 2000, 60: 6-8.PubMed Elders MJ: The increasing impact of arthritis on public health. J Rheumatol Suppl. 2000, 60: 6-8.PubMed
3.
go back to reference DiCesare PE, Abramson SB: Pathogenesis of osteoarthritis. Kelley's Textbook of Rheumatology. Edited by: Harris ED, Ruddy S, Kelley WN. 2005, Philadelphia, PA: Elsevier/Saunders, 2v-(xxix, 1916, lp), 7 DiCesare PE, Abramson SB: Pathogenesis of osteoarthritis. Kelley's Textbook of Rheumatology. Edited by: Harris ED, Ruddy S, Kelley WN. 2005, Philadelphia, PA: Elsevier/Saunders, 2v-(xxix, 1916, lp), 7
5.
go back to reference Hung KE, Kho AT, Sarracino D, Richard LG, Krastins B, Forrester S, Haab BB, Kohane IS, Kucherlapati R: Mass spectrometry-based study of the plasma proteome in a mouse intestinal tumor model. J Proteome Res. 2006, 5: 1866-1878. 10.1021/pr060120r.CrossRefPubMed Hung KE, Kho AT, Sarracino D, Richard LG, Krastins B, Forrester S, Haab BB, Kohane IS, Kucherlapati R: Mass spectrometry-based study of the plasma proteome in a mouse intestinal tumor model. J Proteome Res. 2006, 5: 1866-1878. 10.1021/pr060120r.CrossRefPubMed
6.
go back to reference Misra J, Schmitt W, Hwang D, Hsiao LL, Gullans S, Stephanopoulos G, Stephanopoulos G: Interactive exploration of microarray gene expression patterns in a reduced dimensional space. Genome Res. 2002, 12: 1112-1120. 10.1101/gr.225302.PubMedCentralCrossRefPubMed Misra J, Schmitt W, Hwang D, Hsiao LL, Gullans S, Stephanopoulos G, Stephanopoulos G: Interactive exploration of microarray gene expression patterns in a reduced dimensional space. Genome Res. 2002, 12: 1112-1120. 10.1101/gr.225302.PubMedCentralCrossRefPubMed
7.
go back to reference Kho AT, Zhao Q, Cai Z, Butte AJ, Kim JY, Pomeroy SL, Rowitch DH, Kohane IS: Conserved mechanisms across development and tumorigenesis revealed by a mouse development perspective of human cancers. Genes Dev. 2004, 18: 629-640. 10.1101/gad.1182504.PubMedCentralCrossRefPubMed Kho AT, Zhao Q, Cai Z, Butte AJ, Kim JY, Pomeroy SL, Rowitch DH, Kohane IS: Conserved mechanisms across development and tumorigenesis revealed by a mouse development perspective of human cancers. Genes Dev. 2004, 18: 629-640. 10.1101/gad.1182504.PubMedCentralCrossRefPubMed
8.
go back to reference Alter O, Brown PO, Botstein D: Singular value decomposition for genome-wide expression data processing and modeling. Proc Natl Acad Sci USA. 2000, 97: 10101-10106. 10.1073/pnas.97.18.10101.PubMedCentralCrossRefPubMed Alter O, Brown PO, Botstein D: Singular value decomposition for genome-wide expression data processing and modeling. Proc Natl Acad Sci USA. 2000, 97: 10101-10106. 10.1073/pnas.97.18.10101.PubMedCentralCrossRefPubMed
9.
go back to reference Hollander M, Wolfe DA: Nonparametric Statistical Methods. 1999, New York: Wiley, 2 Hollander M, Wolfe DA: Nonparametric Statistical Methods. 1999, New York: Wiley, 2
10.
go back to reference Rhee DK, Marcelino J, Al-Mayouf S, Schelling DK, Bartels CF, Cui Y, Laxer R, Goldbach-Mansky R, Warman ML: Consequences of disease-causing mutations on lubricin protein synthesis, secretion, and post-translational processing. J Biol Chem. 2005, 280: 31325-31332. 10.1074/jbc.M505401200.CrossRefPubMed Rhee DK, Marcelino J, Al-Mayouf S, Schelling DK, Bartels CF, Cui Y, Laxer R, Goldbach-Mansky R, Warman ML: Consequences of disease-causing mutations on lubricin protein synthesis, secretion, and post-translational processing. J Biol Chem. 2005, 280: 31325-31332. 10.1074/jbc.M505401200.CrossRefPubMed
11.
go back to reference Rhee DK, Marcelino J, Baker M, Gong Y, Smits P, Lefebvre V, Jay GD, Stewart M, Wang H, Warman ML, Carpten JD: The secreted glycoprotein lubricin protects cartilage surfaces and inhibits synovial cell overgrowth. J Clin Invest. 2005, 115: 622-631. 10.1172/JCI200522263.PubMedCentralCrossRefPubMed Rhee DK, Marcelino J, Baker M, Gong Y, Smits P, Lefebvre V, Jay GD, Stewart M, Wang H, Warman ML, Carpten JD: The secreted glycoprotein lubricin protects cartilage surfaces and inhibits synovial cell overgrowth. J Clin Invest. 2005, 115: 622-631. 10.1172/JCI200522263.PubMedCentralCrossRefPubMed
12.
go back to reference Wu CC, MacCoss MJ, Howell KE, Yates JR: A method for the comprehensive proteomic analysis of membrane proteins. Nat Biotechnol. 2003, 21: 532-538. 10.1038/nbt819.CrossRefPubMed Wu CC, MacCoss MJ, Howell KE, Yates JR: A method for the comprehensive proteomic analysis of membrane proteins. Nat Biotechnol. 2003, 21: 532-538. 10.1038/nbt819.CrossRefPubMed
13.
go back to reference Washburn MP, Ulaszek RR, Yates JR: Reproducibility of quantitative proteomic analyses of complex biological mixtures by multidimensional protein identification technology. Anal Chem. 2003, 75: 5054-5061. 10.1021/ac034120b.CrossRefPubMed Washburn MP, Ulaszek RR, Yates JR: Reproducibility of quantitative proteomic analyses of complex biological mixtures by multidimensional protein identification technology. Anal Chem. 2003, 75: 5054-5061. 10.1021/ac034120b.CrossRefPubMed
14.
go back to reference Chen EI, Hewel J, Felding-Habermann B, Yates JR: Large scale protein profiling by combination of protein fractionation and multidimensional protein identification technology (MudPIT). Mol Cell Proteomics. 2006, 5: 53-56. 10.1074/mcp.T500013-MCP200.CrossRefPubMed Chen EI, Hewel J, Felding-Habermann B, Yates JR: Large scale protein profiling by combination of protein fractionation and multidimensional protein identification technology (MudPIT). Mol Cell Proteomics. 2006, 5: 53-56. 10.1074/mcp.T500013-MCP200.CrossRefPubMed
15.
go back to reference Pratta MA, Su JL, Leesnitzer MA, Struglics A, Larsson S, Lohmander LS, Kumar S: Development and characterization of a highly specific and sensitive sandwich ELISA for detection of aggrecanase-generated aggrecan fragments. Osteoarthritis Cartilage. 2006, 14: 702-713. 10.1016/j.joca.2006.01.012.CrossRefPubMed Pratta MA, Su JL, Leesnitzer MA, Struglics A, Larsson S, Lohmander LS, Kumar S: Development and characterization of a highly specific and sensitive sandwich ELISA for detection of aggrecanase-generated aggrecan fragments. Osteoarthritis Cartilage. 2006, 14: 702-713. 10.1016/j.joca.2006.01.012.CrossRefPubMed
16.
go back to reference Struglics A, Larsson S, Pratta MA, Kumar S, Lark MW, Lohmander LS: Human osteoarthritis synovial fluid and joint cartilage contain both aggrecanase- and matrix metalloproteinase-generated aggrecan fragments. Osteoarthritis Cartilage. 2006, 14: 101-113. 10.1016/j.joca.2005.07.018.CrossRefPubMed Struglics A, Larsson S, Pratta MA, Kumar S, Lark MW, Lohmander LS: Human osteoarthritis synovial fluid and joint cartilage contain both aggrecanase- and matrix metalloproteinase-generated aggrecan fragments. Osteoarthritis Cartilage. 2006, 14: 101-113. 10.1016/j.joca.2005.07.018.CrossRefPubMed
17.
go back to reference Poole AR, Ionescu M, Swan A, Dieppe PA: Changes in cartilage metabolism in arthritis are reflected by altered serum and synovial fluid levels of the cartilage proteoglycan aggrecan. Implications for pathogenesis. J Clin Invest. 1994, 94: 25-33.PubMedCentralCrossRefPubMed Poole AR, Ionescu M, Swan A, Dieppe PA: Changes in cartilage metabolism in arthritis are reflected by altered serum and synovial fluid levels of the cartilage proteoglycan aggrecan. Implications for pathogenesis. J Clin Invest. 1994, 94: 25-33.PubMedCentralCrossRefPubMed
18.
go back to reference Lohmander LS, Ionescu M, Jugessur H, Poole AR: Changes in joint cartilage aggrecan after knee injury and in osteoarthritis. Arthritis Rheum. 1999, 42: 534-544. 10.1002/1529-0131(199904)42:3<534::AID-ANR19>3.0.CO;2-J.CrossRefPubMed Lohmander LS, Ionescu M, Jugessur H, Poole AR: Changes in joint cartilage aggrecan after knee injury and in osteoarthritis. Arthritis Rheum. 1999, 42: 534-544. 10.1002/1529-0131(199904)42:3<534::AID-ANR19>3.0.CO;2-J.CrossRefPubMed
19.
go back to reference Rizkalla G, Reiner A, Bogoch E, Poole AR: Studies of the articular cartilage proteoglycan aggrecan in health and osteoarthritis. Evidence for molecular heterogeneity and extensive molecular changes in disease. J Clin Invest. 1992, 90: 2268-2277.PubMedCentralCrossRefPubMed Rizkalla G, Reiner A, Bogoch E, Poole AR: Studies of the articular cartilage proteoglycan aggrecan in health and osteoarthritis. Evidence for molecular heterogeneity and extensive molecular changes in disease. J Clin Invest. 1992, 90: 2268-2277.PubMedCentralCrossRefPubMed
20.
go back to reference Chambers MG, Kuffner T, Cowan SK, Cheah KS, Mason RM: Expression of collagen and aggrecan genes in normal and osteoarthritic murine knee joints. Osteoarthritis Cartilage. 2002, 10: 51-61. 10.1053/joca.2001.0481.CrossRefPubMed Chambers MG, Kuffner T, Cowan SK, Cheah KS, Mason RM: Expression of collagen and aggrecan genes in normal and osteoarthritic murine knee joints. Osteoarthritis Cartilage. 2002, 10: 51-61. 10.1053/joca.2001.0481.CrossRefPubMed
21.
go back to reference Morko JP, Soderstrom M, Saamanen AM, Salminen HJ, Vuorio EI: Up regulation of cathepsin K expression in articular chondrocytes in a transgenic mouse model for osteoarthritis. Ann Rheum Dis. 2004, 63: 649-655. 10.1136/ard.2002.004671.PubMedCentralCrossRefPubMed Morko JP, Soderstrom M, Saamanen AM, Salminen HJ, Vuorio EI: Up regulation of cathepsin K expression in articular chondrocytes in a transgenic mouse model for osteoarthritis. Ann Rheum Dis. 2004, 63: 649-655. 10.1136/ard.2002.004671.PubMedCentralCrossRefPubMed
22.
go back to reference Gabrijelcic D, Annan-Prah A, Rodic B, Rozman B, Cotic V, Turk V: Determination of cathepsins B and H in sera and synovial fluids of patients with different joint diseases. J Clin Chem Clin Biochem. 1990, 28: 149-153.PubMed Gabrijelcic D, Annan-Prah A, Rodic B, Rozman B, Cotic V, Turk V: Determination of cathepsins B and H in sera and synovial fluids of patients with different joint diseases. J Clin Chem Clin Biochem. 1990, 28: 149-153.PubMed
23.
go back to reference Lenarcic B, Gabrijelcic D, Rozman B, Drobnic-Kosorok M, Turk V: Human cathepsin B and cysteine proteinase inhibitors (CPIs) in inflammatory and metabolic joint diseases. Biol Chem Hoppe Seyler. 1988, 369 Suppl (): 257-261.PubMed Lenarcic B, Gabrijelcic D, Rozman B, Drobnic-Kosorok M, Turk V: Human cathepsin B and cysteine proteinase inhibitors (CPIs) in inflammatory and metabolic joint diseases. Biol Chem Hoppe Seyler. 1988, 369 Suppl (): 257-261.PubMed
24.
go back to reference Martel-Pelletier J, Cloutier JM, Pelletier JP: Cathepsin B and cysteine protease inhibitors in human osteoarthritis. J Orthop Res. 1990, 8: 336-344. 10.1002/jor.1100080305.CrossRefPubMed Martel-Pelletier J, Cloutier JM, Pelletier JP: Cathepsin B and cysteine protease inhibitors in human osteoarthritis. J Orthop Res. 1990, 8: 336-344. 10.1002/jor.1100080305.CrossRefPubMed
25.
26.
go back to reference Hou WS, Li W, Keyszer G, Weber E, Levy R, Klein MJ, Gravallese EM, Goldring SR, Bromme D: Comparison of cathepsins K and S expression within the rheumatoid and osteoarthritic synovium. Arthritis Rheum. 2002, 46: 663-674. 10.1002/art.10114.CrossRefPubMed Hou WS, Li W, Keyszer G, Weber E, Levy R, Klein MJ, Gravallese EM, Goldring SR, Bromme D: Comparison of cathepsins K and S expression within the rheumatoid and osteoarthritic synovium. Arthritis Rheum. 2002, 46: 663-674. 10.1002/art.10114.CrossRefPubMed
27.
go back to reference Dodds RA, Connor JR, Drake FH, Gowen M: Expression of cathepsin K messenger RNA in giant cells and their precursors in human osteoarthritic synovial tissues. Arthritis Rheum. 1999, 42: 1588-1593. 10.1002/1529-0131(199908)42:8<1588::AID-ANR4>3.0.CO;2-S.CrossRefPubMed Dodds RA, Connor JR, Drake FH, Gowen M: Expression of cathepsin K messenger RNA in giant cells and their precursors in human osteoarthritic synovial tissues. Arthritis Rheum. 1999, 42: 1588-1593. 10.1002/1529-0131(199908)42:8<1588::AID-ANR4>3.0.CO;2-S.CrossRefPubMed
28.
go back to reference Schittek B, Hipfel R, Sauer B, Bauer J, Kalbacher H, Stevanovic S, Schirle M, Schroeder K, Blin N, Meier F, Garbe C: Dermcidin: a novel human antibiotic peptide secreted by sweat glands. Nat Immunol. 2001, 2: 1133-1137. 10.1038/ni732.CrossRefPubMed Schittek B, Hipfel R, Sauer B, Bauer J, Kalbacher H, Stevanovic S, Schirle M, Schroeder K, Blin N, Meier F, Garbe C: Dermcidin: a novel human antibiotic peptide secreted by sweat glands. Nat Immunol. 2001, 2: 1133-1137. 10.1038/ni732.CrossRefPubMed
29.
go back to reference Rieg S, Seeber S, Steffen H, Humeny A, Kalbacher H, Stevanovic S, Kimura A, Garbe C, Schittek B: Generation of multiple stable dermcidin-derived antimicrobial peptides in sweat of different body sites. J Invest Dermatol. 2006, 126: 354-365. 10.1038/sj.jid.5700041.CrossRefPubMed Rieg S, Seeber S, Steffen H, Humeny A, Kalbacher H, Stevanovic S, Kimura A, Garbe C, Schittek B: Generation of multiple stable dermcidin-derived antimicrobial peptides in sweat of different body sites. J Invest Dermatol. 2006, 126: 354-365. 10.1038/sj.jid.5700041.CrossRefPubMed
30.
go back to reference Ruiz-Romero C, Lopez-Armada MJ, Blanco FJ: Proteomic characterization of human normal articular chondrocytes: a novel tool for the study of osteoarthritis and other rheumatic diseases. Proteomics. 2005, 5: 3048-3059. 10.1002/pmic.200402106.CrossRefPubMed Ruiz-Romero C, Lopez-Armada MJ, Blanco FJ: Proteomic characterization of human normal articular chondrocytes: a novel tool for the study of osteoarthritis and other rheumatic diseases. Proteomics. 2005, 5: 3048-3059. 10.1002/pmic.200402106.CrossRefPubMed
31.
go back to reference Ruiz-Romero C, Lopez-Armada MJ, Blanco FJ: Mitochondrial proteomic characterization of human normal articular chondrocytes. Osteoarthritis Cartilage. 2006, 14: 507-518. 10.1016/j.joca.2005.12.004.CrossRefPubMed Ruiz-Romero C, Lopez-Armada MJ, Blanco FJ: Mitochondrial proteomic characterization of human normal articular chondrocytes. Osteoarthritis Cartilage. 2006, 14: 507-518. 10.1016/j.joca.2005.12.004.CrossRefPubMed
32.
go back to reference Yoshida K, Suzuki Y, Saito A, Fukuda K, Hamanishi C, Munakata H: Aggrecanase-1 (ADAMTS-4) interacts with alpha1-antitrypsin. Biochim Biophys Acta. 2005, 1725: 152-159.CrossRefPubMed Yoshida K, Suzuki Y, Saito A, Fukuda K, Hamanishi C, Munakata H: Aggrecanase-1 (ADAMTS-4) interacts with alpha1-antitrypsin. Biochim Biophys Acta. 2005, 1725: 152-159.CrossRefPubMed
33.
go back to reference Fischer DC, Siebertz B, van de Leur E, Schiwy-Bochat KH, Graeve L, Heinrich PC, Haubeck HD: Induction of alpha1-antitrypsin synthesis in human articular chondrocytes by interleukin-6-type cytokines: evidence for a local acute-phase response in the joint. Arthritis Rheum. 1999, 42: 1936-1945. 10.1002/1529-0131(199909)42:9<1936::AID-ANR20>3.0.CO;2-K.CrossRefPubMed Fischer DC, Siebertz B, van de Leur E, Schiwy-Bochat KH, Graeve L, Heinrich PC, Haubeck HD: Induction of alpha1-antitrypsin synthesis in human articular chondrocytes by interleukin-6-type cytokines: evidence for a local acute-phase response in the joint. Arthritis Rheum. 1999, 42: 1936-1945. 10.1002/1529-0131(199909)42:9<1936::AID-ANR20>3.0.CO;2-K.CrossRefPubMed
34.
go back to reference Beatty K, Bieth J, Travis J: Kinetics of association of serine proteinases with native and oxidized alpha-1-proteinase inhibitor and alpha-1-antichymotrypsin. J Biol Chem. 1980, 255: 3931-3934.PubMed Beatty K, Bieth J, Travis J: Kinetics of association of serine proteinases with native and oxidized alpha-1-proteinase inhibitor and alpha-1-antichymotrypsin. J Biol Chem. 1980, 255: 3931-3934.PubMed
35.
go back to reference Belcher C, Fawthrop F, Bunning R, Doherty M: Plasminogen activators and their inhibitors in synovial fluids from normal, osteoarthritis, and rheumatoid arthritis knees. Ann Rheum Dis. 1996, 55: 230-236.PubMedCentralCrossRefPubMed Belcher C, Fawthrop F, Bunning R, Doherty M: Plasminogen activators and their inhibitors in synovial fluids from normal, osteoarthritis, and rheumatoid arthritis knees. Ann Rheum Dis. 1996, 55: 230-236.PubMedCentralCrossRefPubMed
36.
go back to reference Kummer JA, Abbink JJ, de Boer JP, Roem D, Nieuwenhuys EJ, Kamp AM, Swaak TJ, Hack CE: Analysis of intraarticular fibrinolytic pathways in patients with inflammatory and noninflammatory joint diseases. Arthritis Rheum. 1992, 35: 884-893. 10.1002/art.1780350806.CrossRefPubMed Kummer JA, Abbink JJ, de Boer JP, Roem D, Nieuwenhuys EJ, Kamp AM, Swaak TJ, Hack CE: Analysis of intraarticular fibrinolytic pathways in patients with inflammatory and noninflammatory joint diseases. Arthritis Rheum. 1992, 35: 884-893. 10.1002/art.1780350806.CrossRefPubMed
37.
go back to reference Saxne T, Lecander I, Geborek P: Plasminogen activators and plasminogen activator inhibitors in synovial fluid. Difference between inflammatory joint disorders and osteoarthritis. J Rheumatol. 1993, 20: 91-96.PubMed Saxne T, Lecander I, Geborek P: Plasminogen activators and plasminogen activator inhibitors in synovial fluid. Difference between inflammatory joint disorders and osteoarthritis. J Rheumatol. 1993, 20: 91-96.PubMed
38.
go back to reference Brommer EJ, Dooijewaard G, Dijkmans BA, Breedveld FC: Depression of tissue-type plasminogen activator and enhancement of urokinase-type plasminogen activator as an expression of local inflammation. Thromb Haemost. 1992, 68: 180-184.PubMed Brommer EJ, Dooijewaard G, Dijkmans BA, Breedveld FC: Depression of tissue-type plasminogen activator and enhancement of urokinase-type plasminogen activator as an expression of local inflammation. Thromb Haemost. 1992, 68: 180-184.PubMed
39.
go back to reference Busso N, Peclat V, So A, Sappino AP: Plasminogen activation in synovial tissues: differences between normal, osteoarthritis, and rheumatoid arthritis joints. Ann Rheum Dis. 1997, 56: 550-557.PubMedCentralCrossRefPubMed Busso N, Peclat V, So A, Sappino AP: Plasminogen activation in synovial tissues: differences between normal, osteoarthritis, and rheumatoid arthritis joints. Ann Rheum Dis. 1997, 56: 550-557.PubMedCentralCrossRefPubMed
40.
go back to reference Murphy G, Atkinson S, Ward R, Gavrilovic J, Reynolds JJ: The role of plasminogen activators in the regulation of connective tissue metalloproteinases. Ann NY Acad Sci. 1992, 667: 1-12. 10.1111/j.1749-6632.1992.tb51590.x.CrossRefPubMed Murphy G, Atkinson S, Ward R, Gavrilovic J, Reynolds JJ: The role of plasminogen activators in the regulation of connective tissue metalloproteinases. Ann NY Acad Sci. 1992, 667: 1-12. 10.1111/j.1749-6632.1992.tb51590.x.CrossRefPubMed
41.
go back to reference Philip A, Bostedt L, Stigbrand T, O'Connor-McCourt MD: Binding of transforming growth factor-beta (TGF-beta) to pregnancy zone protein (PZP). Comparison to the TGF-beta-alpha 2-macroglobulin interaction. Eur J Biochem. 1994, 221: 687-693. 10.1111/j.1432-1033.1994.tb18781.x.CrossRefPubMed Philip A, Bostedt L, Stigbrand T, O'Connor-McCourt MD: Binding of transforming growth factor-beta (TGF-beta) to pregnancy zone protein (PZP). Comparison to the TGF-beta-alpha 2-macroglobulin interaction. Eur J Biochem. 1994, 221: 687-693. 10.1111/j.1432-1033.1994.tb18781.x.CrossRefPubMed
42.
go back to reference Clemmons DR, Busby WH, Garmong A, Schultz DR, Howell DS, Altman RD, Karr R: Inhibition of insulin-like growth factor binding protein 5 proteolysis in articular cartilage and joint fluid results in enhanced concentrations of insulin-like growth factor 1 and is associated with improved osteoarthritis. Arthritis Rheum. 2002, 46: 694-703. 10.1002/art.10222.CrossRefPubMed Clemmons DR, Busby WH, Garmong A, Schultz DR, Howell DS, Altman RD, Karr R: Inhibition of insulin-like growth factor binding protein 5 proteolysis in articular cartilage and joint fluid results in enhanced concentrations of insulin-like growth factor 1 and is associated with improved osteoarthritis. Arthritis Rheum. 2002, 46: 694-703. 10.1002/art.10222.CrossRefPubMed
43.
go back to reference Lee DM, Kiener HP, Brenner MB: Synoviocytes. Kelley's Textbook of Rheumatology. Edited by: Harris ED, Ruddy S, Kelley WN. 2005, Philadelphia, PA: Elsevier/Saunders, 2v-(xxix, 1916, lp), 7 Lee DM, Kiener HP, Brenner MB: Synoviocytes. Kelley's Textbook of Rheumatology. Edited by: Harris ED, Ruddy S, Kelley WN. 2005, Philadelphia, PA: Elsevier/Saunders, 2v-(xxix, 1916, lp), 7
44.
go back to reference Close DR: Matrix metalloproteinase inhibitors in rheumatic diseases. Ann Rheum Dis. 2001, 60 Suppl 3 (): iii62-iii67.PubMed Close DR: Matrix metalloproteinase inhibitors in rheumatic diseases. Ann Rheum Dis. 2001, 60 Suppl 3 (): iii62-iii67.PubMed
45.
go back to reference Egeblad M, Werb Z: New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer. 2002, 2: 161-174. 10.1038/nrc745.CrossRefPubMed Egeblad M, Werb Z: New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer. 2002, 2: 161-174. 10.1038/nrc745.CrossRefPubMed
46.
go back to reference Fassina G, Ferrari N, Brigati C, Benelli R, Santi L, Noonan DM, Albini A: Tissue inhibitors of metalloproteases: regulation and biological activities. Clin Exp Metastasis. 2000, 18: 111-120. 10.1023/A:1006797522521.CrossRefPubMed Fassina G, Ferrari N, Brigati C, Benelli R, Santi L, Noonan DM, Albini A: Tissue inhibitors of metalloproteases: regulation and biological activities. Clin Exp Metastasis. 2000, 18: 111-120. 10.1023/A:1006797522521.CrossRefPubMed
47.
go back to reference Wojtowicz-Praga S, Torri J, Johnson M, Steen V, Marshall J, Ness E, Dickson R, Sale M, Rasmussen HS, Chiodo TA, Hawkins MJ: Phase I trial of Marimastat, a novel matrix metalloproteinase inhibitor, administered orally to patients with advanced lung cancer. J Clin Oncol. 1998, 16: 2150-2156.PubMed Wojtowicz-Praga S, Torri J, Johnson M, Steen V, Marshall J, Ness E, Dickson R, Sale M, Rasmussen HS, Chiodo TA, Hawkins MJ: Phase I trial of Marimastat, a novel matrix metalloproteinase inhibitor, administered orally to patients with advanced lung cancer. J Clin Oncol. 1998, 16: 2150-2156.PubMed
48.
go back to reference Rasmussen HS, McCann PP: Matrix metalloproteinase inhibition as a novel anticancer strategy: a review with special focus on batimastat and marimastat. Pharmacol Ther. 1997, 75: 69-75. 10.1016/S0163-7258(97)00023-5.CrossRefPubMed Rasmussen HS, McCann PP: Matrix metalloproteinase inhibition as a novel anticancer strategy: a review with special focus on batimastat and marimastat. Pharmacol Ther. 1997, 75: 69-75. 10.1016/S0163-7258(97)00023-5.CrossRefPubMed
49.
go back to reference Nemunaitis J, Poole C, Primrose J, Rosemurgy A, Malfetano J, Brown P, Berrington A, Cornish A, Lynch K, Rasmussen H, et al: Combined analysis of studies of the effects of the matrix metalloproteinase inhibitor marimastat on serum tumor markers in advanced cancer: selection of a biologically active and tolerable dose for longer-term studies. Clin Cancer Res. 1998, 4: 1101-1109.PubMed Nemunaitis J, Poole C, Primrose J, Rosemurgy A, Malfetano J, Brown P, Berrington A, Cornish A, Lynch K, Rasmussen H, et al: Combined analysis of studies of the effects of the matrix metalloproteinase inhibitor marimastat on serum tumor markers in advanced cancer: selection of a biologically active and tolerable dose for longer-term studies. Clin Cancer Res. 1998, 4: 1101-1109.PubMed
50.
go back to reference Hofmann MA, Drury S, Fu C, Qu W, Taguchi A, Lu Y, Avila C, Kambham N, Bierhaus A, Nawroth P, et al: RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell. 1999, 97: 889-901. 10.1016/S0092-8674(00)80801-6.CrossRefPubMed Hofmann MA, Drury S, Fu C, Qu W, Taguchi A, Lu Y, Avila C, Kambham N, Bierhaus A, Nawroth P, et al: RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell. 1999, 97: 889-901. 10.1016/S0092-8674(00)80801-6.CrossRefPubMed
51.
go back to reference Valencia JV, Mone M, Zhang J, Weetall M, Buxton FP, Hughes TE: Divergent pathways of gene expression are activated by the RAGE ligands S100b and AGE-BSA. Diabetes. 2004, 53: 743-751. 10.2337/diabetes.53.3.743.CrossRefPubMed Valencia JV, Mone M, Zhang J, Weetall M, Buxton FP, Hughes TE: Divergent pathways of gene expression are activated by the RAGE ligands S100b and AGE-BSA. Diabetes. 2004, 53: 743-751. 10.2337/diabetes.53.3.743.CrossRefPubMed
52.
go back to reference Yan SD, Schmidt AM, Anderson GM, Zhang J, Brett J, Zou YS, Pinsky D, Stern D: Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J Biol Chem. 1994, 269: 9889-9897.PubMed Yan SD, Schmidt AM, Anderson GM, Zhang J, Brett J, Zou YS, Pinsky D, Stern D: Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J Biol Chem. 1994, 269: 9889-9897.PubMed
53.
go back to reference Lander HM, Tauras JM, Ogiste JS, Hori O, Moss RA, Schmidt AM: Activation of the receptor for advanced glycation end products triggers a p21(ras)-dependent mitogen-activated protein kinase pathway regulated by oxidant stress. J Biol Chem. 1997, 272: 17810-17814. 10.1074/jbc.272.28.17810.CrossRefPubMed Lander HM, Tauras JM, Ogiste JS, Hori O, Moss RA, Schmidt AM: Activation of the receptor for advanced glycation end products triggers a p21(ras)-dependent mitogen-activated protein kinase pathway regulated by oxidant stress. J Biol Chem. 1997, 272: 17810-17814. 10.1074/jbc.272.28.17810.CrossRefPubMed
54.
go back to reference Loeser RF, Yammani RR, Carlson CS, Chen H, Cole A, Im HJ, Bursch LS, Yan SD: Articular chondrocytes express the receptor for advanced glycation end products: potential role in osteoarthritis. Arthritis Rheum. 2005, 52: 2376-2385. 10.1002/art.21199.PubMedCentralCrossRefPubMed Loeser RF, Yammani RR, Carlson CS, Chen H, Cole A, Im HJ, Bursch LS, Yan SD: Articular chondrocytes express the receptor for advanced glycation end products: potential role in osteoarthritis. Arthritis Rheum. 2005, 52: 2376-2385. 10.1002/art.21199.PubMedCentralCrossRefPubMed
55.
go back to reference Huttunen HJ, Fages C, Rauvala H: Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways. J Biol Chem. 1999, 274: 19919-19924. 10.1074/jbc.274.28.19919.CrossRefPubMed Huttunen HJ, Fages C, Rauvala H: Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways. J Biol Chem. 1999, 274: 19919-19924. 10.1074/jbc.274.28.19919.CrossRefPubMed
56.
go back to reference Jerkovic L, Voegele AF, Chwatal S, Kronenberg F, Radcliffe CM, Wormald MR, Lobentanz EM, Ezeh B, Eller P, Dejori N, et al: Afamin is a novel human vitamin E-binding glycoprotein characterization and in vitro expression. J Proteome Res. 2005, 4: 889-899. 10.1021/pr0500105.CrossRefPubMed Jerkovic L, Voegele AF, Chwatal S, Kronenberg F, Radcliffe CM, Wormald MR, Lobentanz EM, Ezeh B, Eller P, Dejori N, et al: Afamin is a novel human vitamin E-binding glycoprotein characterization and in vitro expression. J Proteome Res. 2005, 4: 889-899. 10.1021/pr0500105.CrossRefPubMed
57.
go back to reference Ricciarelli R, Zingg JM, Azzi A: Vitamin E: protective role of a Janus molecule. FASEB J. 2001, 15: 2314-2325. 10.1096/fj.01-0258rev.CrossRefPubMed Ricciarelli R, Zingg JM, Azzi A: Vitamin E: protective role of a Janus molecule. FASEB J. 2001, 15: 2314-2325. 10.1096/fj.01-0258rev.CrossRefPubMed
58.
go back to reference Connor JR, Kumar S, Sathe G, Mooney J, O'Brien SP, Mui P, Murdock PR, Gowen M, Lark MW: Clusterin expression in adult human normal and osteoarthritic articular cartilage. Osteoarthritis Cartilage. 2001, 9: 727-737. 10.1053/joca.2001.0475.CrossRefPubMed Connor JR, Kumar S, Sathe G, Mooney J, O'Brien SP, Mui P, Murdock PR, Gowen M, Lark MW: Clusterin expression in adult human normal and osteoarthritic articular cartilage. Osteoarthritis Cartilage. 2001, 9: 727-737. 10.1053/joca.2001.0475.CrossRefPubMed
59.
go back to reference Zhang H, Kim JK, Edwards CA, Xu Z, Taichman R, Wang CY: Clusterin inhibits apoptosis by interacting with activated Bax. Nat Cell Biol. 2005, 7: 909-915. 10.1038/ncb1291.CrossRefPubMed Zhang H, Kim JK, Edwards CA, Xu Z, Taichman R, Wang CY: Clusterin inhibits apoptosis by interacting with activated Bax. Nat Cell Biol. 2005, 7: 909-915. 10.1038/ncb1291.CrossRefPubMed
60.
go back to reference Worthy K, Figueroa CD, Dieppe PA, Bhoola KD: Kallikreins and kinins: mediators in inflammatory joint disease?. Int J Exp Pathol. 1990, 71: 587-601.PubMedCentralPubMed Worthy K, Figueroa CD, Dieppe PA, Bhoola KD: Kallikreins and kinins: mediators in inflammatory joint disease?. Int J Exp Pathol. 1990, 71: 587-601.PubMedCentralPubMed
61.
go back to reference Bhoola KD, Elson CJ, Dieppe PA: Kinins: key mediators in inflammatory arthritis?. Br J Rheumatol. 1992, 31: 509-518. 10.1093/rheumatology/31.8.509.CrossRefPubMed Bhoola KD, Elson CJ, Dieppe PA: Kinins: key mediators in inflammatory arthritis?. Br J Rheumatol. 1992, 31: 509-518. 10.1093/rheumatology/31.8.509.CrossRefPubMed
62.
go back to reference Pelc LR, Gross GJ, Warltier DC: Mechanism of coronary vasodilation produced by bradykinin. Circulation. 1991, 83: 2048-2056.CrossRefPubMed Pelc LR, Gross GJ, Warltier DC: Mechanism of coronary vasodilation produced by bradykinin. Circulation. 1991, 83: 2048-2056.CrossRefPubMed
63.
go back to reference McIntyre TM, Zimmerman GA, Satoh K, Prescott SM: Cultured endothelial cells synthesize both platelet-activating factor and prostacyclin in response to histamine, bradykinin, and adenosine triphosphate. J Clin Invest. 1985, 76: 271-280.PubMedCentralCrossRefPubMed McIntyre TM, Zimmerman GA, Satoh K, Prescott SM: Cultured endothelial cells synthesize both platelet-activating factor and prostacyclin in response to histamine, bradykinin, and adenosine triphosphate. J Clin Invest. 1985, 76: 271-280.PubMedCentralCrossRefPubMed
64.
go back to reference Colman RW, Stadnicki A, Kettner CA, Adam AA, DeLa Cadena RA, Sartor RB: Activation of the kallikrein-kinin system in arthritis and enterocolitis in genetically susceptible rats: modulation by a selective plasma kallikrein inhibitor. Proc Assoc Am Physicians. 1997, 109: 10-22.PubMed Colman RW, Stadnicki A, Kettner CA, Adam AA, DeLa Cadena RA, Sartor RB: Activation of the kallikrein-kinin system in arthritis and enterocolitis in genetically susceptible rats: modulation by a selective plasma kallikrein inhibitor. Proc Assoc Am Physicians. 1997, 109: 10-22.PubMed
65.
go back to reference Sheikh IA, Kaplan AP: Assessment of kininases in rheumatic diseases and the effect of therapeutic agents. Arthritis Rheum. 1987, 30: 138-145. 10.1002/art.1780300203.CrossRefPubMed Sheikh IA, Kaplan AP: Assessment of kininases in rheumatic diseases and the effect of therapeutic agents. Arthritis Rheum. 1987, 30: 138-145. 10.1002/art.1780300203.CrossRefPubMed
66.
go back to reference Bond AP, Lemon M, Dieppe PA, Bhoola KD: Generation of kinins in synovial fluid from patients with arthropathy. Immunopharmacology. 1997, 36: 209-216. 10.1016/S0162-3109(97)00023-4.CrossRefPubMed Bond AP, Lemon M, Dieppe PA, Bhoola KD: Generation of kinins in synovial fluid from patients with arthropathy. Immunopharmacology. 1997, 36: 209-216. 10.1016/S0162-3109(97)00023-4.CrossRefPubMed
67.
go back to reference Neumann E, Barnum SR, Tarner IH, Echols J, Fleck M, Judex M, Kullmann F, Mountz JD, Scholmerich J, Gay S, Muller-Ladner U: Local production of complement proteins in rheumatoid arthritis synovium. Arthritis Rheum. 2002, 46: 934-945. 10.1002/art.10183.CrossRefPubMed Neumann E, Barnum SR, Tarner IH, Echols J, Fleck M, Judex M, Kullmann F, Mountz JD, Scholmerich J, Gay S, Muller-Ladner U: Local production of complement proteins in rheumatoid arthritis synovium. Arthritis Rheum. 2002, 46: 934-945. 10.1002/art.10183.CrossRefPubMed
68.
go back to reference Ruddy S, Colten HR: Rheumatoid arthritis. Biosynthesis of complement proteins by synovial tissues. N Engl J Med. 1974, 290: 1284-1288.CrossRefPubMed Ruddy S, Colten HR: Rheumatoid arthritis. Biosynthesis of complement proteins by synovial tissues. N Engl J Med. 1974, 290: 1284-1288.CrossRefPubMed
69.
go back to reference Katz Y, Strunk RC: Synovial fibroblast-like cells synthesize seven proteins of the complement system. Arthritis Rheum. 1988, 31: 1365-1370. 10.1002/art.1780311104.CrossRefPubMed Katz Y, Strunk RC: Synovial fibroblast-like cells synthesize seven proteins of the complement system. Arthritis Rheum. 1988, 31: 1365-1370. 10.1002/art.1780311104.CrossRefPubMed
70.
go back to reference Firestein GS, Paine MM, Littman BH: Gene expression (collagenase, tissue inhibitor of metalloproteinases, complement, and HLA-DR) in rheumatoid arthritis and osteoarthritis synovium. Quantitative analysis and effect of intraarticular corticosteroids. Arthritis Rheum. 1991, 34: 1094-1105. 10.1002/art.1780340905.CrossRefPubMed Firestein GS, Paine MM, Littman BH: Gene expression (collagenase, tissue inhibitor of metalloproteinases, complement, and HLA-DR) in rheumatoid arthritis and osteoarthritis synovium. Quantitative analysis and effect of intraarticular corticosteroids. Arthritis Rheum. 1991, 34: 1094-1105. 10.1002/art.1780340905.CrossRefPubMed
71.
go back to reference Breitner S, Storkel S, Reichel W, Loos M: Complement components C1q, C1r/C1s, and C1INH in rheumatoid arthritis. Correlation of in situ hybridization and northern blot results with function and protein concentration in synovium and primary cell cultures. Arthritis Rheum. 1995, 38: 492-498. 10.1002/art.1780380406.CrossRefPubMed Breitner S, Storkel S, Reichel W, Loos M: Complement components C1q, C1r/C1s, and C1INH in rheumatoid arthritis. Correlation of in situ hybridization and northern blot results with function and protein concentration in synovium and primary cell cultures. Arthritis Rheum. 1995, 38: 492-498. 10.1002/art.1780380406.CrossRefPubMed
72.
go back to reference Olmez U, Garred P, Mollnes TE, Harboe M, Berntzen HB, Munthe E: C3 activation products, C3 containing immune complexes, the terminal complement complex and native C9 in patients with rheumatoid arthritis. Scand J Rheumatol. 1991, 20: 183-189.CrossRefPubMed Olmez U, Garred P, Mollnes TE, Harboe M, Berntzen HB, Munthe E: C3 activation products, C3 containing immune complexes, the terminal complement complex and native C9 in patients with rheumatoid arthritis. Scand J Rheumatol. 1991, 20: 183-189.CrossRefPubMed
73.
go back to reference Collard CD, Lekowski R, Jordan JE, Agah A, Stahl GL: Complement activation following oxidative stress. Mol Immunol. 1999, 36: 941-948. 10.1016/S0161-5890(99)00116-9.CrossRefPubMed Collard CD, Lekowski R, Jordan JE, Agah A, Stahl GL: Complement activation following oxidative stress. Mol Immunol. 1999, 36: 941-948. 10.1016/S0161-5890(99)00116-9.CrossRefPubMed
74.
go back to reference Doherty M, Richards N, Hornby J, Powell R: Relation between synovial fluid C3 degradation products and local joint inflammation in rheumatoid arthritis, osteoarthritis, and crystal associated arthropathy. Ann Rheum Dis. 1988, 47: 190-197.PubMedCentralCrossRefPubMed Doherty M, Richards N, Hornby J, Powell R: Relation between synovial fluid C3 degradation products and local joint inflammation in rheumatoid arthritis, osteoarthritis, and crystal associated arthropathy. Ann Rheum Dis. 1988, 47: 190-197.PubMedCentralCrossRefPubMed
75.
go back to reference Corvetta A, Pomponio G, Rinaldi N, Luchetti MM, Di Loreto C, Stramazzotti D: Terminal complement complex in synovial tissue from patients affected by rheumatoid arthritis, osteoarthritis and acute joint trauma. Clin Exp Rheumatol. 1992, 10: 433-438.PubMed Corvetta A, Pomponio G, Rinaldi N, Luchetti MM, Di Loreto C, Stramazzotti D: Terminal complement complex in synovial tissue from patients affected by rheumatoid arthritis, osteoarthritis and acute joint trauma. Clin Exp Rheumatol. 1992, 10: 433-438.PubMed
76.
go back to reference Collins T, Winkelstein JA, Sullivan KE: Regulation of early complement components C3 and C4 in the synovium. Clin Diagn Lab Immunol. 1996, 3: 5-9.PubMedCentralPubMed Collins T, Winkelstein JA, Sullivan KE: Regulation of early complement components C3 and C4 in the synovium. Clin Diagn Lab Immunol. 1996, 3: 5-9.PubMedCentralPubMed
77.
go back to reference Eyre DR, Wu JJ, Apone S: A growing family of collagens in articular cartilage: identification of 5 genetically distinct types. J Rheumatol. 1987, 25-27. 14 Spec No Eyre DR, Wu JJ, Apone S: A growing family of collagens in articular cartilage: identification of 5 genetically distinct types. J Rheumatol. 1987, 25-27. 14 Spec No
78.
go back to reference Swoboda B, Pullig O, Kirsch T, Kladny B, Steinhauser B, Weseloh G: Increased content of type-VI collagen epitopes in human osteoarthritic cartilage: quantitation by inhibition ELISA. J Orthop Res. 1998, 16: 96-99. 10.1002/jor.1100160116.CrossRefPubMed Swoboda B, Pullig O, Kirsch T, Kladny B, Steinhauser B, Weseloh G: Increased content of type-VI collagen epitopes in human osteoarthritic cartilage: quantitation by inhibition ELISA. J Orthop Res. 1998, 16: 96-99. 10.1002/jor.1100160116.CrossRefPubMed
79.
go back to reference Lohmander LS, Saxne T, Heinegard DK: Release of cartilage oligomeric matrix protein (COMP) into joint fluid after knee injury and in osteoarthritis. Ann Rheum Dis. 1994, 53: 8-13.PubMedCentralCrossRefPubMed Lohmander LS, Saxne T, Heinegard DK: Release of cartilage oligomeric matrix protein (COMP) into joint fluid after knee injury and in osteoarthritis. Ann Rheum Dis. 1994, 53: 8-13.PubMedCentralCrossRefPubMed
80.
go back to reference Saxne T, Glennas A, Kvien TK, Melby K, Heinegard D: Release of cartilage macromolecules into the synovial fluid in patients with acute and prolonged phases of reactive arthritis. Arthritis Rheum. 1993, 36: 20-25. 10.1002/art.1780360105.CrossRefPubMed Saxne T, Glennas A, Kvien TK, Melby K, Heinegard D: Release of cartilage macromolecules into the synovial fluid in patients with acute and prolonged phases of reactive arthritis. Arthritis Rheum. 1993, 36: 20-25. 10.1002/art.1780360105.CrossRefPubMed
81.
go back to reference Hedbom E, Antonsson P, Hjerpe A, Aeschlimann D, Paulsson M, Rosa-Pimentel E, Sommarin Y, Wendel M, Oldberg A, Heinegard D: Cartilage matrix proteins. An acidic oligomeric protein (COMP) detected only in cartilage. J Biol Chem. 1992, 267: 6132-6136.PubMed Hedbom E, Antonsson P, Hjerpe A, Aeschlimann D, Paulsson M, Rosa-Pimentel E, Sommarin Y, Wendel M, Oldberg A, Heinegard D: Cartilage matrix proteins. An acidic oligomeric protein (COMP) detected only in cartilage. J Biol Chem. 1992, 267: 6132-6136.PubMed
82.
go back to reference Knudson CB, Knudson W: Cartilage proteoglycans. Semin Cell Dev Biol. 2001, 12: 69-78. 10.1006/scdb.2000.0243.CrossRefPubMed Knudson CB, Knudson W: Cartilage proteoglycans. Semin Cell Dev Biol. 2001, 12: 69-78. 10.1006/scdb.2000.0243.CrossRefPubMed
83.
go back to reference Jay GD, Tantravahi U, Britt DE, Barrach HJ, Cha CJ: Homology of lubricin and superficial zone protein (SZP): products of megakaryocyte stimulating factor (MSF) gene expression by human synovial fibroblasts and articular chondrocytes localized to chromosome 1q25. J Orthop Res. 2001, 19: 677-687. 10.1016/S0736-0266(00)00040-1.CrossRefPubMed Jay GD, Tantravahi U, Britt DE, Barrach HJ, Cha CJ: Homology of lubricin and superficial zone protein (SZP): products of megakaryocyte stimulating factor (MSF) gene expression by human synovial fibroblasts and articular chondrocytes localized to chromosome 1q25. J Orthop Res. 2001, 19: 677-687. 10.1016/S0736-0266(00)00040-1.CrossRefPubMed
84.
go back to reference Lorenzo P, Bayliss MT, Heinegard D: A novel cartilage protein (CILP) present in the mid-zone of human articular cartilage increases with age. J Biol Chem. 1998, 273: 23463-23468. 10.1074/jbc.273.36.23463.CrossRefPubMed Lorenzo P, Bayliss MT, Heinegard D: A novel cartilage protein (CILP) present in the mid-zone of human articular cartilage increases with age. J Biol Chem. 1998, 273: 23463-23468. 10.1074/jbc.273.36.23463.CrossRefPubMed
85.
go back to reference Lorenzo P, Neame P, Sommarin Y, Heinegard D: Cloning and deduced amino acid sequence of a novel cartilage protein (CILP) identifies a proform including a nucleotide pyrophosphohydrolase. J Biol Chem. 1998, 273: 23469-23475. 10.1074/jbc.273.36.23469.CrossRefPubMed Lorenzo P, Neame P, Sommarin Y, Heinegard D: Cloning and deduced amino acid sequence of a novel cartilage protein (CILP) identifies a proform including a nucleotide pyrophosphohydrolase. J Biol Chem. 1998, 273: 23469-23475. 10.1074/jbc.273.36.23469.CrossRefPubMed
86.
go back to reference Martin JA, Brown TD, Heiner AD, Buckwalter JA: Chondrocyte senescence, joint loading and osteoarthritis. Clin Orthop Relat Res. 2004, S96-S103. 10.1097/01.blo.0000143818.74887.b1. 427 Suppl Martin JA, Brown TD, Heiner AD, Buckwalter JA: Chondrocyte senescence, joint loading and osteoarthritis. Clin Orthop Relat Res. 2004, S96-S103. 10.1097/01.blo.0000143818.74887.b1. 427 Suppl
87.
go back to reference Buckwalter JA, Lappin DR: The disproportionate impact of chronic arthralgia and arthritis among women. Clin Orthop Relat Res. 2000, 372: 159-168. 10.1097/00003086-200003000-00018.CrossRefPubMed Buckwalter JA, Lappin DR: The disproportionate impact of chronic arthralgia and arthritis among women. Clin Orthop Relat Res. 2000, 372: 159-168. 10.1097/00003086-200003000-00018.CrossRefPubMed
88.
go back to reference Buckwalter JA, Mankin HJ: Articular cartilage: degeneration and osteoarthritis, repair, regeneration, and transplantation. Instr Course Lect. 1998, 47: 487-504.PubMed Buckwalter JA, Mankin HJ: Articular cartilage: degeneration and osteoarthritis, repair, regeneration, and transplantation. Instr Course Lect. 1998, 47: 487-504.PubMed
Metadata
Title
High abundance synovial fluid proteome: distinct profiles in health and osteoarthritis
Authors
Reuben Gobezie
Alvin Kho
Bryan Krastins
David A Sarracino
Thomas S Thornhill
Michael Chase
Peter J Millett
David M Lee
Publication date
01-04-2007
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue 2/2007
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/ar2172

Other articles of this Issue 2/2007

Arthritis Research & Therapy 2/2007 Go to the issue